Bionovo, Inc. announced it will be presenting the positive results from the phase 2 clinical trial of their lead drug candidate for postmenopausal symptoms, Menerba, to the international community at the 8th Annual European Society for Gynecology in Rome, Italy.
Bionovo (bnvi) to present positive results from phase 2 trial of Menerba